A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

por Dutta, B, Pusztai, L, Qi, Y, André, F, Lazar, V, Bianchini, G, Ueno, N, Agarwal, R, Wang, B, Shiang, C Y, Hortobagyi, G N, Mills, G B, Symmans, W F, Balázsi, G
Publicado 2012

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

por Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Publicado 2012

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway

por Maseki, S, Ijichi, K, Tanaka, H, Fujii, M, Hasegawa, Y, Ogawa, T, Murakami, S, Kondo, E, Nakanishi, H
Publicado 2012

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

por Robertson, L, Hanson, H, Seal, S, Warren-Perry, M, Hughes, D, Howell, I, Turnbull, C, Houlston, R, Shanley, S, Butler, S, Evans, D G, Ross, G, Eccles, D, Tutt, A, Rahman, N
Publicado 2012

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

por Cuzick, J, Berney, D M, Fisher, G, Mesher, D, Møller, H, Reid, J E, Perry, M, Park, J, Younus, A, Gutin, A, Foster, C S, Scardino, P, Lanchbury, J S, Stone, S
Publicado 2012

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

por Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Publicado 2012

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation

por Fallowfield, L J, Kilburn, L S, Langridge, C, Snowdon, C F, Bliss, J M, Coombes, R C
Publicado 2012

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

por Yoon, D H, Ryu, M-H, Park, Y S, Lee, H J, Lee, C, Ryoo, B-Y, Lee, J-L, Chang, H-M, Kim, T W, Kang, Y-K
Publicado 2012

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

por Tikidzhieva, A, Benner, A, Michel, S, Formentini, A, Link, K-H, Dippold, W, von Knebel Doeberitz, M, Kornmann, M, Kloor, M
Publicado 2012

Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study

por Thomas, S, Pütter, C, Weber, S, Bornfeld, N, Lohmann, D R, Zeschnigk, M
Publicado 2012

Hedgehog pathway activation in human transitional cell carcinoma of the bladder

por Pignot, G, Vieillefond, A, Vacher, S, Zerbib, M, Debre, B, Lidereau, R, Amsellem-Ouazana, D, Bieche, I
Publicado 2012

The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

por Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C
Publicado 2012

Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis

por Verry, H, Lord, S J, Martin, A, Gill, G, Lee, C K, Howard, K, Wetzig, N, Simes, J
Publicado 2012

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia

por Agarwal, R, Harding, V, Short, D, Fisher, R A, Sebire, N J, Harvey, R, Patel, D, Savage, P M, Lim, A K P, Seckl, M J
Publicado 2012

Skin cancer screening participation and impact on melanoma incidence in Germany – an observational study on incidence trends in regions with and without population-based screening...

por Waldmann, A, Nolte, S, Weinstock, M A, Breitbart, E W, Eisemann, N, Geller, A C, Greinert, R, Volkmer, B, Katalinic, A
Publicado 2012

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoid...

por Sharp, L, Tilson, L, Whyte, S, O'Ceilleachair, A, Walsh, C, Usher, C, Tappenden, P, Chilcott, J, Staines, A, Barry, M, Comber, H
Publicado 2012

Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide study

por Frederiksen, B L, Dalton, S O, Osler, M, Steding-Jessen, M, de Nully Brown, P
Publicado 2012

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

por Eberhard, J, Gaber, A, Wangefjord, S, Nodin, B, Uhlén, M, Ericson Lindquist, K, Jirström, K
Publicado 2012

Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma

por Miyagaki, H, Yamasaki, M, Miyata, H, Takahashi, T, Kurokawa, Y, Nakajima, K, Takiguchi, S, Fujiwara, Y, Ishii, H, Tanaka, F, Mori, M, Doki, Y
Publicado 2012

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis

por de Martino, M, Hoetzenecker, K, Ankersmit, H J, Roth, G A, Haitel, A, Waldert, M, Klatte, T
Publicado 2012